CEACAM5 and metastasis: In the multivariate analysis, unfavourable disease-free survival was associated with preoperational carcinoembryonic antigen levels above 2.12 ng/mL (P = 0.022), IAC pathology (P = 0.046), confirmed lymphatic metastasis (P < 0.001), and advanced pathological stage (P = 0.033).